The transcriptional profile of coronary arteritis in Kawasaki disease

Anne H Rowley1,2,3, Kristine M Wylie4,5, Kwang-Youn A Kim6

  • 1Department of Pediatrics, Northwestern University Feinberg School of Medicine, 310 E Superior Street, Morton 4-685B, Chicago, IL, 60611, USA. a-rowley@northwestern.edu.

BMC Genomics
|December 19, 2015
PubMed

Insights

Kawasaki disease (KD) coronary arteries show an antiviral immune response, with upregulated T cell activation and interferon pathways. This finding offers insights into KD pathogenesis and potential new treatments.

Area of Science:

  • Cardiovascular Research
  • Immunology
  • Pediatric Infectious Diseases

Background:

  • Kawasaki disease (KD) is a serious childhood illness causing coronary arteritis with a suspected infectious origin.
  • Understanding the gene expression in affected tissues is crucial for diagnosing and treating KD.
  • RNA sequencing offers a powerful method to explore the host response in KD.

Purpose of the Study:

  • To investigate the gene expression profile in coronary artery tissues of children with Kawasaki disease.
  • To identify potential etiological factors and host responses contributing to KD pathogenesis.
  • To explore new diagnostic and therapeutic strategies for KD.

Main Methods:

  • Deep RNA sequencing was performed on coronary artery tissues from 8 KD patients and 7 healthy children.
  • Bioinformatics analysis identified 1074 differentially expressed messenger RNAs (mRNAs).
  • Microbial sequences were analyzed for association with KD using a specialized platform and Metastats.

Main Results:

  • Significant upregulation of T lymphocyte activation, antigen presentation, immunoglobulin production, and type I interferon response in KD arteritis.
  • No differential expression was observed in the tumor necrosis factor α pathway.
  • No specific association was found between transcripts of known infectious agents and KD coronary arteritis.

Conclusions:

  • The immune transcriptional profile in KD coronary arteries exhibits characteristics of an antiviral response.
  • Upregulation of cytotoxic T lymphocyte and type I interferon-induced genes suggests a specific host response in KD.
  • These findings can inform the development of novel immunomodulatory therapies for high-risk KD patients and guide future etiological research.
Abstract

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
955
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.6K
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
552
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
421
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.0K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
709